Stock Analysis
DaVita Inc. (DVA) Stock Analysis
DaVita Inc. (DVA) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
DaVita Inc. (DVA) currently has an AIQ Score of 59/100, indicating a neutral setup. Value is the strongest factor at 68/100. Quality is the weakest current factor at 44/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
DVA at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $181.55 |
| AIQ Score | 59/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Neutral |
| Market Cap | $11.31B |
| P/E Ratio | 13.76 |
| Forward P/E | — |
| EPS | $4.10 |
| Revenue TTM | $3.55B |
| Dividend Yield | 0.01% |
| Beta | 0.87 |
| Volume | 767.85K |
| 52-week range | $101.00-$247.49 |
| RSI 14 | 62.62 |
| 50-Day SMA | $205.06 |
| 200-Day SMA | $165.37 |
| Analyst Price Target | $227.36 |
| Next Earnings | Oct 28, 2026 |
DVA
OverviewDVA Stock Analysis Summary
DaVita Inc. (DVA) currently has an AIQ Score of 59/100, indicating a neutral setup. Value is the strongest factor at 68/100. Quality is the weakest current factor at 44/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, DVA has AIQ Score of 59/100 with Value base of 68/100 and fading Quality at 44/100. Wait for component alignment before adding exposure.
Value (68/100) leads while Quality (44/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.12% stock move · DVA classified in Medical - Care Facilities.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is DVA Bullish or Bearish Right Now?
DVA currently has a neutral overall setup. Value is the strongest factor at 68/100, while Quality is weakest at 44/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 66/100.
- - Analyst target implies +25.23% upside from the latest quote.
- - Technical consensus has more sell votes than buy votes (20 vs 19).
Current Consensus
DVA's Technical Analysis Consensus is currently Neutral, with 19 buy, 6 neutral, and 20 sell votes. DVA's 14-day RSI is 62.62, which places the stock in a constructive momentum range. DVA's beta is 0.87, indicating market sensitivity broadly in line with the market.
What Changed in DVA?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the DVA Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
DVA Decision Framework
Public evidence layers, setup checks, and risk context for DaVita Inc..
DaVita Inc. (DVA) Stock Analysis
DaVita Inc. has an AIQ Score of 59/100 in a Neutral regime. Value is strongest at 68/100. Beta is 0.87, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | DVA is in a Neutral AIQ regime with score 59/100. |
| Signal Conflict | The primary conflict is that value leads at 68/100 while quality lags at 44/100. |
| Factor Evidence | Momentum 66/100 · Value 68/100 · Quality 44/100 · Risk 57/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 68/100.
Momentum is 66/100 and RSI (14) is 62.6.
DVA is in a Neutral regime at 59/100.
Risk factor is 57/100 with beta 0.87 and annual volatility 45.08%.
Current conflict: value leads at 68/100 while quality lags at 44/100.
DVA Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
DVA Fundamentals
DVA valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
DVA Technical Analysis
DVA technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
DVA Stock Catalysts
Track DVA earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
DVA Dividend Analysis
DVA dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
DVA Financial Data
DVA revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
DVA Risk Analysis
DVA volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
DVA Stock News
DVA stock news, market tone, recent headlines, and catalyst context.
DVA vs Healthcare Services / Managed Care Peers
Current peer cohort: DVA · EHC · ELV · HCA · HCAT. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| DVA Current stock | 59/100 | 68/100 | 66/100 | 57/100 | 0.83 | 45.08% | Current |
| EHC Encompass Health | 63/100 | 57/100 | 65/100 | 60/100 | -0.08 | 28.80% | DVA vs EHC |
| ELV Elevance Health | 63/100 | 68/100 | 76/100 | 63/100 | 0.95 | 35.26% | DVA vs ELV |
| HCA HCA Healthcare | 53/100 | 67/100 | 54/100 | 43/100 | 0.28 | 30.75% | DVA vs HCA |
| HCAT Health Catalyst | 50/100 | 73/100 | 58/100 | 39/100 | -0.34 | 89.92% | DVA vs HCAT |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching DVA
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for DVA
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
DVA Stock FAQ
What is DVA stock price today?
DaVita Inc.'s current stock price is $181.55. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is DVA bullish or bearish right now?
DVA's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is DVA's market cap?
DVA's market cap is $11.31B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is DVA's current P/E ratio?
DVA's current P/E ratio is 13.76 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is DVA's RSI?
DVA's 14-day RSI is 62.62 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is DVA above its 50-day and 200-day moving averages?
DVA is -11.46% from its 50-day SMA and 9.78% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is DVA's next earnings date?
DVA's next earnings date is currently listed as Oct 28, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does DVA pay a dividend?
DVA's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.